Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioannis Dimitrakopoulos

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Medicina (Kaunas, Lithuania)|June 27, 2024
Expression of Pluripotency Factors OCT4 and LIN28 Correlates with Survival Outcome in Lung AdenocarcinomaPinelopi Bosgana, Sophia Nikou, Foteinos-Ioannis Dimitrakopoulos, et al.
Journal of Environmental Management|July 9, 2026
Safeguarding biodiversity through predictive modelling of illegal wildlife poisoning hotspotsAnastasios Bounas, Kalliopi Baxevani, Ioannis Dimitrakopoulos, et al.
Cancers|December 11, 2025
The Prognostic Role of Different Blood Cell Count-to-Lymphocyte Ratios in Patients with Lung Cancer at DiagnosisOurania Papaioannou, Oraianthi Fiste, Eva Theohari, et al.
Cancers|May 21, 2020
PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response, Progression-Free Survival, and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) InhibitorsFoteinos-Ioannis Dimitrakopoulos, Achilleas Nikolakopoulos, Anastasia Kottorou, et al.
Current Molecular Pharmacology|September 2, 2020
H3K4 Methylation Status and Lysine Specific Methyltransferase KMT2C Expression Correlate with Prognosis in Lung AdenocarcinomaPinelopi Bosgana, Sophia Nikou, Foteinos-Ioannis Dimitrakopoulos, et al.
Translational Oncology|October 19, 2020
NF-κB2 and RELB offer prognostic information in colorectal cancer and NFKB2 rs7897947 represents a genetic risk factor for disease developmentAnna Antonacopoulou, Anastasia E Kottorou, Foteinos-Ioannis Dimitrakopoulos, et al.
International Journal of Environmental Research and Public Health|September 23, 2022
Self-Assessment of Health Professionals' Cultural Competence: Knowledge, Skills, and Mental Health Concepts for Optimal Health CareAlexandros Argyriadis, Evridiki Patelarou, Panagiotis Paoullis, et al.
Journal of Medical Cases|February 12, 2025
An Adverse Double-Hit by Pembrolizumab: A Case Report of Bullous Pemphigoid and PneumonitisChristodoulos Chatzigrigoriadis, Prodromos Avramidis, Christos Davoulos, et al.
In Vivo (Athens, Greece)|April 29, 2021
Radiotherapy and Renal Cell Carcinoma: A Continuing SagaDespoina Spyropoulou, Panagiotis Tsiganos, Foteinos-Ioannis Dimitrakopoulos, et al.
Molecular Carcinogenesis|June 22, 2010
Prion protein expression and the M129V polymorphism of the PRNP gene in patients with colorectal cancerAnna G Antonacopoulou, Maria Palli, Stella Marousi, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Medicina (Kaunas, Lithuania)|June 27, 2024
Expression of Pluripotency Factors OCT4 and LIN28 Correlates with Survival Outcome in Lung AdenocarcinomaPinelopi Bosgana, Sophia Nikou, Foteinos-Ioannis Dimitrakopoulos, et al.
Journal of Environmental Management|July 9, 2026
Safeguarding biodiversity through predictive modelling of illegal wildlife poisoning hotspotsAnastasios Bounas, Kalliopi Baxevani, Ioannis Dimitrakopoulos, et al.
Cancers|December 11, 2025
The Prognostic Role of Different Blood Cell Count-to-Lymphocyte Ratios in Patients with Lung Cancer at DiagnosisOurania Papaioannou, Oraianthi Fiste, Eva Theohari, et al.
Cancers|May 21, 2020
PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response, Progression-Free Survival, and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) InhibitorsFoteinos-Ioannis Dimitrakopoulos, Achilleas Nikolakopoulos, Anastasia Kottorou, et al.
Current Molecular Pharmacology|September 2, 2020
H3K4 Methylation Status and Lysine Specific Methyltransferase KMT2C Expression Correlate with Prognosis in Lung AdenocarcinomaPinelopi Bosgana, Sophia Nikou, Foteinos-Ioannis Dimitrakopoulos, et al.
Translational Oncology|October 19, 2020
NF-κB2 and RELB offer prognostic information in colorectal cancer and NFKB2 rs7897947 represents a genetic risk factor for disease developmentAnna Antonacopoulou, Anastasia E Kottorou, Foteinos-Ioannis Dimitrakopoulos, et al.
International Journal of Environmental Research and Public Health|September 23, 2022
Self-Assessment of Health Professionals' Cultural Competence: Knowledge, Skills, and Mental Health Concepts for Optimal Health CareAlexandros Argyriadis, Evridiki Patelarou, Panagiotis Paoullis, et al.
Journal of Medical Cases|February 12, 2025
An Adverse Double-Hit by Pembrolizumab: A Case Report of Bullous Pemphigoid and PneumonitisChristodoulos Chatzigrigoriadis, Prodromos Avramidis, Christos Davoulos, et al.
In Vivo (Athens, Greece)|April 29, 2021
Radiotherapy and Renal Cell Carcinoma: A Continuing SagaDespoina Spyropoulou, Panagiotis Tsiganos, Foteinos-Ioannis Dimitrakopoulos, et al.
Molecular Carcinogenesis|June 22, 2010
Prion protein expression and the M129V polymorphism of the PRNP gene in patients with colorectal cancerAnna G Antonacopoulou, Maria Palli, Stella Marousi, et al.
Pageof 6